Dr Güldane Cengiz Seval speaks to ecancer about her experience treating multiple myeloma in Turkey.

She begins by detailing the International Staging System (R2-ISS) and Mayo Additive Staging System (MASS) and how these are aiding treatment decision and patient management.

Dr Cengiz Seval then shares findings from a study that she presented on 'post-induction MRD' at IMS 2023.

She also discusses some of the issues facing multiple myeloma treatment in Turkey and gives her thoughts on possible solutions.